Frankfurt am Main, Germany

Rolf Horlein


Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Kelkheim/Taunus, DE (1993)
  • Frankfurt-am-Main, DE (1995 - 1997)

Company Filing History:


Years Active: 1993-1997

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Rolf Horlein: A Journey through Cephem Prodrug Esters

Introduction

Rolf Horlein is a distinguished inventor based in Frankfurt am Main, Germany, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio consisting of five patents, he has made notable advancements, particularly in the preparation of cephem prodrug esters.

Latest Patents

Rolf Horlein's latest inventions reflect his expertise in pharmaceutical chemistry. One of his prominent patents involves a novel process for the preparation of cephem prodrug esters. This process includes compounds of the formula II and is designed to enhance the efficacy of cephem antibiotics. The invention further specifies methods involving various alkanoyloxy and alkoxycarbonyloxy groups, along with specific inorganic or organic anions, demonstrating his innovative approach to improving medicinal compounds.

Career Highlights

Rolf has had a commendable career at Hoechst Aktiengesellschaft, a prominent pharmaceutical company where he has dedicated his efforts to research and development. His work has not only contributed to his company's success but also advanced the science of drug formulation, paving the way for new therapeutic options.

Collaborations

Throughout his career, Rolf has collaborated with various talented professionals, including his coworkers Rudolf Lattrell and Gerd Fischer. These partnerships have allowed him to share knowledge, merge expertise, and drive innovation within their projects, leading to impactful inventions in the pharmaceutical industry.

Conclusion

Rolf Horlein stands out as a key figure in pharmaceutical innovation, with his notable patents highlighting his commitment to improving drug effectiveness through advanced chemical processes. His work at Hoechst Aktiengesellschaft, combined with fruitful collaborations, positions him as an influential inventor, shaping the future of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…